Management of Rare Causes of Pediatric Chronic Respiratory Failure

Jenny Shi1, Nawal Al-Shamli1, Jackie Chiang1

  • 1The Division of Respiratory Medicine, Department of Pediatrics, The Hospital for Sick Children, 4539 Hill Wing, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada; The University of Toronto, Toronto, Ontario, Canada.

Sleep Medicine Clinics
|November 2, 2020
PubMed

Insights

Noninvasive positive pressure ventilation (NiPPV) is increasingly vital for pediatric chronic respiratory failure. This review details NiPPV considerations and indications in children, including rare conditions.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Medical Technology

Background:

  • The prevalence of chronic respiratory failure in children requiring long-term ventilatory support is increasing.
  • Noninvasive positive pressure ventilation (NiPPV) offers a less invasive alternative to traditional mechanical ventilation.
  • Pediatric patients present unique physiological and clinical challenges for respiratory support.

Purpose of the Study:

  • To review the pediatric-specific considerations for implementing noninvasive positive pressure ventilation (NiPPV) therapy.
  • To outline the primary indications for NiPPV in children with chronic respiratory failure.
  • To discuss the application of NiPPV in specific rare pediatric conditions.

Main Methods:

  • Literature review of pediatric noninvasive positive pressure ventilation.
  • Categorization of NiPPV indications based on the etiology of respiratory failure.
  • Examination of NiPPV use in specific pediatric neuromuscular and congenital disorders.

Main Results:

  • NiPPV indications in children are diverse, stemming from upper airway obstruction, neuromuscular diseases, lower respiratory tract issues, and breathing control abnormalities.
  • The review highlights the growing need and application of NiPPV in pediatric chronic respiratory failure.
  • Specific rare conditions like spinal muscular atrophy and congenital central hypoventilation syndrome benefit from NiPPV.

Conclusions:

  • NiPPV is a crucial therapy for managing pediatric chronic respiratory failure, with tailored approaches needed for different underlying causes.
  • Understanding pediatric-specific factors is essential for optimizing NiPPV efficacy and patient outcomes.
  • Further research and clinical guidelines are important for advancing NiPPV in pediatric populations.

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
324
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
555
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.7K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
594
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
820
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.1K